These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3165077

  • 21. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
    Kikuchi Y, Kita T, Iwano I, Kuki E, Oomori K, Kizawa I.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):69-76. PubMed ID: 2926196
    [Abstract] [Full Text] [Related]

  • 22. Relative operating characteristic analysis and group modeling for tumor markers: comparison of CA 15.3, carcinoembryonic antigen, and mucin-like carcinoma-associated antigen in breast carcinoma.
    Silver HK, Archibald BL, Ragaz J, Coldman AJ.
    Cancer Res; 1991 Apr 01; 51(7):1904-9. PubMed ID: 2004374
    [Abstract] [Full Text] [Related]

  • 23. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.
    Lumachi F, Brandes AA, Boccagni P, Polistina F, Favia G, D'Amico DF.
    Anticancer Res; 1999 Apr 01; 19(5C):4485-9. PubMed ID: 10650797
    [Abstract] [Full Text] [Related]

  • 24. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D, Nürnberg R, Bahlo M, Klapdor R.
    Anticancer Res; 1999 Apr 01; 19(4A):2443-50. PubMed ID: 10470173
    [Abstract] [Full Text] [Related]

  • 25. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
    Okamura Y, Takatsuka Y, Katoh T, Tsumura I, Kobayakawa K, Kawahara T.
    Gan To Kagaku Ryoho; 1991 Jul 01; 18(8):1279-85. PubMed ID: 2069399
    [Abstract] [Full Text] [Related]

  • 26. CEA and CA 19-9 as prognostic indexes in colorectal cancer.
    Forones NM, Tanaka M.
    Hepatogastroenterology; 1999 Jul 01; 46(26):905-8. PubMed ID: 10370636
    [Abstract] [Full Text] [Related]

  • 27. Predictive value of CEA and CA 15-3 in the follow up of invasive breast cancer.
    Sütterlin M, Bussen S, Trott S, Caffier H.
    Anticancer Res; 1999 Jul 01; 19(4A):2567-70. PubMed ID: 10470196
    [Abstract] [Full Text] [Related]

  • 28. A comparative study of four serological tumor markers for the detection of breast cancer.
    Clinton SR, Beason KL, Bryant S, Johnson JT, Jackson M, Wilson C, Holifield K, Vincent C, Hall M.
    Biomed Sci Instrum; 2003 Jul 01; 39():408-14. PubMed ID: 12724928
    [Abstract] [Full Text] [Related]

  • 29. [Tumor markers in the upper intestinal tract--stomach and pancreas].
    Pointner R, Conrad F, Schwab G.
    Wien Klin Wochenschr; 1989 Jul 14; 101(14):482-4. PubMed ID: 2773485
    [Abstract] [Full Text] [Related]

  • 30. [Study for clinical usefulness of CEA, TPA, CA15-3 and BCA225 in breast cancer].
    Kaneko Y, Imoto S, Kasakura S.
    Rinsho Byori; 1995 Jul 14; 43(7):696-702. PubMed ID: 7674542
    [Abstract] [Full Text] [Related]

  • 31. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ, Diez M, Rodriguez A, Ratia T, Martin Duce A, Galvan M, Granell J, Coca C.
    Anticancer Res; 2003 Jul 14; 23(4):3427-32. PubMed ID: 12926084
    [Abstract] [Full Text] [Related]

  • 32. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
    Giai M, Roagna R, Ponzone R, Biglia N, Sgro L, Perona M, Sismondi P.
    Anticancer Res; 1996 Jul 14; 16(2):875-81. PubMed ID: 8687144
    [Abstract] [Full Text] [Related]

  • 33. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A, Stellos K, Matthaios D, Petrakis G, Parmenopoulou V, Babatsikou F, Matthaiou E, Theodosiadou E, Hountis P, Koutis C.
    J BUON; 2009 Jul 14; 14(3):463-72. PubMed ID: 19810140
    [Abstract] [Full Text] [Related]

  • 34. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R, Caffier H, Paulick M.
    Cancer Detect Prev; 1987 Jul 14; 10(3-4):197-203. PubMed ID: 3568016
    [Abstract] [Full Text] [Related]

  • 35. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L, Topolcan O, Pikner R, Pecen L, Vaclavickova J, Wirthova M, Molacek J, Stieber P, Holdenrieder S, Sen LH, Finek J.
    Anticancer Res; 2000 Jul 14; 20(6D):5237-44. PubMed ID: 11326702
    [Abstract] [Full Text] [Related]

  • 36. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
    Zöller J, Fiehn W, Mende U, Hotz G.
    Dtsch Z Mund Kiefer Gesichtschir; 1990 Jul 14; 14(4):254-9. PubMed ID: 2134649
    [Abstract] [Full Text] [Related]

  • 37. Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
    Ebeling FC, Schmitt UM, Untch M, Nagel D, Fateh-Moghadam A, Stieber P, Seidel D.
    Anticancer Res; 1999 Jul 14; 19(4A):2545-50. PubMed ID: 10470192
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of serum CA549, CA M26 and CA M29 levels in the post-operative follow-up of breast cancer patients.
    Nicolini A, Ferdeghini M, Colombini C, Carpi A.
    J Nucl Med Allied Sci; 1990 Jul 14; 34(4):309-13. PubMed ID: 2090796
    [Abstract] [Full Text] [Related]

  • 39. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F, Ferroni P, Carlini S, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M.
    Clin Cancer Res; 2001 Aug 14; 7(8):2357-62. PubMed ID: 11489813
    [Abstract] [Full Text] [Related]

  • 40. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
    Paulick R, Caffier H.
    Geburtshilfe Frauenheilkd; 1985 Nov 14; 45(11):774-9. PubMed ID: 4076751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.